Huberman Lab

Dr. Michael Kilgard on Huberman Lab: How to Rewire Brains

Vagus nerve stimulation releases neuromodulators at precise moments; Kilgard shows this rewires the adult brain for stroke recovery, tinnitus, and PTSD.

AHAndrew HubermanhostMKDr. Michael Kilgardguest

Aug 11, 2025·3h 9m·Watch on YouTube ↗

📖 CHAPTERS

1. 1
   0:00 – 7:10

   Neuroplasticity: From Fixed Wiring to Lifelong Change

   Huberman introduces Dr. Michael Kilgard as a leading neuroplasticity researcher whose work overturned the dogma that adult brains are largely fixed. They define plasticity, contrast historical views of “hardwired” brains with modern evidence of ongoing rewiring, and emphasize the scale and dynamism of synaptic change throughout life.

2. 2
   7:10 – 25:00

   Childhood Plasticity, Parenting, and the Power of Real Experiences

   Huberman asks how a neuroplasticity researcher parents his own children. Kilgard explains that young brains are “sponges,” that every little experience contributes to wiring, and that while details matter, no single event usually determines a child’s fate. They discuss overemphasis on the first six years and the importance of rich, naturalistic environments.

3. 3
   25:00 – 1:00:50

   Video Games, Phones, and the Statistics of the Natural World

   The conversation turns to technology’s impact on developing brains. Kilgard distinguishes between ‘real’ experiences with natural statistics (multisensory, 3D, coherent) and artificial, manipulated environments (video games, social feeds) that may not generalize well to real-world skills and can overdrive neuromodulator systems.

4. 4
   1:00:50 – 1:35:50

   Focus, Friction, Reflection, and Sleep: Ingredients of Lasting Learning

   Huberman proposes a mental model of plasticity requiring focus plus friction (effort/challenge) plus sleep; Kilgard adds reflection and mental rehearsal as key amplifiers. They connect these ideas to research on self-testing, visualization in elite athletes, and how modern phone use may crowd out crucial reflective time.

5. 5
   1:35:50 – 2:06:40

   Genes, Synapses, and the Four-Factor Learning Rule

   Kilgard explains why genes alone cannot specify the brain’s 150 trillion synapses and emphasizes experience-driven wiring. He discusses Hebbian learning, spike-timing–dependent plasticity, and the crucial role of neuromodulators arriving seconds later to confirm or cancel pending synaptic changes—what he calls the synaptic eligibility trace.

6. 6
   2:06:40 – 2:23:20

   From Lab to Clinic: Vagus Nerve Stimulation as a Plasticity Tool

   Building on neuromodulator science, Kilgard describes shifting from deep brain stimulation to vagus nerve stimulation (VNS) as a more practical way to drive plasticity. By electrically mimicking brief “heart–lung alarm” signals in the vagus, his team can evoke synchronized acetylcholine, norepinephrine, and serotonin release—then pair those pulses with specific behaviors in rehab.

7. 7
   2:23:20 – 2:34:10

   Clinical Results: Stroke, Spinal Cord Injury, Tinnitus, and PTSD

   They review human trials where VNS paired with task-specific therapy led to unexpectedly large improvements. Kilgard contrasts these results with many failed attempts to use drugs like SSRIs or stem cells to enhance recovery. He also explains tinnitus mechanisms and how VNS-sound pairing aims to retune auditory cortex.

8. 8
   2:34:10 – 2:55:00

   Drugs, Psychedelics, and the Limits of Global Neuromodulator Boosting

   Huberman raises the parallel universe of pharmacologic plasticity enhancers—SSRIs, nicotine, stimulants, psychedelics. Kilgard explains why his group spent years trying to pair drugs with training and mostly failed: elevating neuromodulators everywhere, all the time, doesn’t tell synapses *which* activity to reinforce.

9. 9
   2:55:00 – 3:09:35

   Complex Problems, Combination Therapies, and Cautious Optimism

   In closing, they zoom out to reflect on why neurological and psychiatric diseases are so hard to treat compared to infections, and why it was rational—but insufficient—to pursue simple, gene- or drug-only explanations. Kilgard argues for embracing complexity, combining devices, drugs, and behavioral therapies, and maintaining optimism grounded in concrete successes like cochlear implants and VNS.